IFN-I may either restrain or promote tumor growth depending on the duration and intensity of the transduced signaling, two features that jointly delineate the patterns of ISG expression, so-called IFN signature14, and shape the accessibility to chromatin, so-called IFN-mediated epigenomic signature35,36. The gene discussed is IFNA1; the disease is neoplasm.